A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus–Seronegative Men-Reference-Cited by-同舟云学术

A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus–Seronegative Men

Published:2016-08-11 Issue:9 Volume:214 Page:1341-1348
ISSN:0022-1899
Container-title:Journal of Infectious Diseases
language:en
Short-container-title:J Infect Dis.

Author:

Adler Stuart P.,Manganello Anne-Marie,Lee Ronzo,McVoy Michael A.,Nixon Daniel E.,Plotkin Stanley,Mocarski Edward,Cox Josephine H.,Fast Patricia E.,Nesterenko Pavlo A.,Murray Susan E.,Hill Ann B.,Kemble George

Funder

National Institutes of Health

International AIDS Vaccine Initiative

US Agency for International Development

IAVI

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/214/9/1341/17412618/jiw365.pdf

Reference34 articles.

1. The Outcome of Congenital Cytomegalovirus Infection in Relation to Maternal Antibody Status

2. Stratton KR , Durch J , Lawrence RS . Vaccines for the 21st century: a tool for decision making. Washington, DC: National Academy Press, 2000.

3. The history of vaccination against cytomegalovirus

4. Development of a vaccine against mental retardation cased by cytomegalovirus infection in utero;Elek;Lancet,1974

5. Candidate cytomegalovirus strain for human vaccination;Plotkin;Infect Immun,1975

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV Vaccine Development at a Crossroads: New B and T Cell Approaches;Vaccines;2024-09-12

2. Re-Evaluating Human Cytomegalovirus Vaccine Design: Prediction of T Cell Epitopes;Vaccines;2023-10-24

3. SMAC mimetics inhibit human T cell proliferation and fail to augment type 1 cytokine responses;Cellular Immunology;2023-02

4. Management of neonatal central nervous system viral infections: Knowledge gaps and research priorities;Reviews in Medical Virology;2023-01-13

5. Cytomegalovirus Vaccines;Plotkin's Vaccines;2023